EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Super‐Enhancer Target Gene CBP/p300‐Interacting Transactivator With Glu/Asp‐Rich C‐Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling

Songyue Li, Jingya Zhang, Xu Wang, Xinru Wang, Yuyu Song, Xinyue Song, Xiuli Wang, Weiwei Cao, Chong Zhao, Jing Qi, Xiaodong Zheng iD, Yan Xing iD

Cell Proliferation · 2025

DOI: 10.1111/cpr.13817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, 2025. Verfasst von Songyue Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Harbin Medical University-Daqing, Daqing, Heilongjiang, People's Republic of China. Hauptthemen laut MEDLINE: Forkhead Transcription Factors, Repressor Proteins, Vascular Remodeling, Trans-Activators. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Heilongjiang Postdoctoral Scientific Research Developmental Fund, Heilongjiang Natural Science Foundation Joint Guidance Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The function of super‐enhancers (SEs) in pulmonary hypertension (PH), especially in the proliferation of pulmonary artery smooth muscle cells (PASMCs), is currently unknown. We identified SEs‐targeted genes in PASMCs with chromatin immunoprecipitation (ChIP)‐sequence by H3K27ac antibody and proved that CBP/p300‐interacting transactivator with Glu/Asp‐rich C‐terminal domain, 2 (CITED2) is an SEs‐targeted gene through bioinformatics prediction, ChIP‐PCR, dual‐luciferase reporter gene assays and other experimental methods. We also found that the expression of CITED2 and the transcription factor Forkhead Box J3 (FOXJ3) was reduced in hypoxic mouse PASMCs. In addition, the expression of CITED2 and FOXJ3 also decreased in both the patients with idiopathic pulmonary arterial hypertension (iPAH) and the human PASMCs exposed to hypoxia. The decreased expression of CITED2 was reversed by co‐transfection of FOXJ3 and SEs plasmids. Overexpressing of CITED2 attenuated the PASMCs proliferation induced by hypoxia. Lentiviral overexpression of CITED2 also reversed hypoxia‐induced pulmonary hypertension mice model. Mechanically, the expression of CITED2 by affecting by FOXJ3, which binding with three SEs located in the about 2000 bp of TSS. In conclusion, we first identified that CITED2 is a kind of SEs‐targeted gene, modulated by FOXJ3. The FOXJ3/SEs/CITED2 axis may become a new therapeutic target of PH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Transcription FactorsRepressor ProteinsVascular RemodelingTrans-ActivatorsAnimalsHumansMiceCell ProliferationPulmonary ArteryMyocytes, Smooth MuscleMaleMice, Inbred C57BLHypertension, PulmonaryCell HypoxiaCells, Cultured

Stichwörter der Autor:innen

cell proliferationpulmonary hypertensionsuper‐enhancer

Substanzen

Forkhead Transcription FactorsRepressor ProteinsCITED2 protein, humanTrans-ActivatorsCited2 protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacology, Harbin Medical University-Daqing, Daqing, Heilongjiang, People's Republic of China.
  • Central Laboratory, Harbin Medical University-Daqing, Daqing, Heilongjiang, People's Republic of China.
  • Department of Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, People's Republic of China.
  • Department of Pharmaceutical Analysis, Harbin Medical University-Daqing, Heilongjiang, People's Republic of China.
  • Department of Literature Retrieval, Harbin Medical University-Daqing, Heilongjiang, People's Republic of China.
  • Department of Medical Genetics, Harbin Medical University-Daqing, Daqing, Heilongjiang, People's Republic of China.

ORCID-Profile: Xiaodong Zheng, Yan Xing

Förderung

  • National Natural Science Foundation of China
  • Heilongjiang Postdoctoral Scientific Research Developmental Fund
  • Heilongjiang Natural Science Foundation Joint Guidance Project
  • Fundamental Research Funds for the Provincial Universities
  • Construction Project of Scientific Research and Innovation Team of Harbin Medical University-Daqing

Zitieren

APA

Li, S., Zhang, J., Wang, X., Wang, X., Song, Y., Song, X., Wang, X., Cao, W., Zhao, C., Qi, J., Zheng, X., & Xing, Y. (2025). Super‐Enhancer Target Gene CBP/p300‐Interacting Transactivator With Glu/Asp‐Rich C‐Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling. Cell Proliferation. https://doi.org/10.1111/cpr.13817

Vancouver

Li S, Zhang J, Wang X, Wang X, Song Y, Song X, et al. Super‐Enhancer Target Gene CBP/p300‐Interacting Transactivator With Glu/Asp‐Rich C‐Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling. Cell Proliferation. 2025. doi:10.1111/cpr.13817

BibTeX
@article{Li2025,
  author = {Li, Songyue and Zhang, Jingya and Wang, Xu and Wang, Xinru and Song, Yuyu and Song, Xinyue and Wang, Xiuli and Cao, Weiwei and Zhao, Chong and Qi, Jing and Zheng, Xiaodong and Xing, Yan},
  title = {Super‐Enhancer Target Gene CBP/p300‐Interacting Transactivator With Glu/Asp‐Rich C‐Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling},
  journal = {Cell Proliferation},
  year = {2025},
  doi = {10.1111/cpr.13817}
}
Kostenlos starten →